Which Labs Are Needed Before My Doctor Visit?

At a glance
- Core panels / CMP, lipid panel, CBC, HbA1c, and thyroid function (TSH, free T4, free T3) form the baseline for most visits
- Fasting window / 8 to 12 hours of fasting is standard for accurate glucose, insulin, and lipid readings
- Timing / Labs drawn within 30 days of your visit give the most actionable snapshot; most clinics accept results up to 90 days old
- Thyroid detail / TSH alone misses 10 to 15% of subclinical thyroid dysfunction; free T3 and free T4 provide a fuller picture
- HbA1c threshold / A value of 5.7% or above signals prediabetes and changes the treatment algorithm for weight management
- Add-ons for hormone therapy / Testosterone (total and free), estradiol, DHEA-S, and SHBG are typical before TRT or HRT consultations
- Vitamin D / Deficiency (below 20 ng/mL) affects roughly 42% of U.S. Adults and can mimic fatigue and mood symptoms
- Liver markers / ALT and AST are included in the CMP; GGT may be added if GLP-1 or metabolic-associated steatotic liver disease (MASLD) screening is relevant
- Cost range / Most of these panels are covered by insurance with a standard order; self-pay pricing through Quest or Labcorp runs $100 to $250 for a full set
Why Pre-Visit Labs Matter for Metabolic Health
Getting blood work done before your appointment lets your clinician interpret results in real time rather than scheduling a follow-up weeks later. A 2021 analysis in the Journal of General Internal Medicine found that pre-visit lab completion reduced time-to-treatment-decision by a median of 18 days for patients with new metabolic diagnoses [1]. That gap matters when conditions like prediabetes or subclinical hypothyroidism are progressing.
Baseline Data Drives the Conversation
Without labs, your provider is working from symptoms alone. A fasting glucose of 112 mg/dL, for example, shifts a "fatigue and weight gain" visit from a lifestyle-only conversation to one that includes insulin sensitizer options like metformin. Labs turn subjective complaints into objective starting points.
Safety Screening Before Prescribing
Many metabolic and hormone medications require organ function checks. GLP-1 receptor agonists carry a boxed warning regarding medullary thyroid carcinoma risk, making a baseline thyroid panel non-negotiable before prescribing [2]. Testosterone therapy demands a hematocrit and PSA check. Pre-visit labs satisfy these safety gates on day one.
Insurance and Telehealth Requirements
Most telehealth metabolic programs, including those modeled on the Calibrate framework, require labs within 90 days. Some insurers will not authorize GLP-1 prescriptions without a documented HbA1c or BMI-qualifying lab panel. Having results in hand prevents prior authorization delays that can stretch four to six weeks.
The Core Lab Panels Every Visit Needs
Five panels cover roughly 90% of what a metabolic health or hormone therapy provider will need on a first visit. These are the non-negotiable starting point.
Comprehensive Metabolic Panel (CMP)
The CMP includes 14 markers: glucose, BUN, creatinine, eGFR, sodium, potassium, chloride, CO2, calcium, total protein, albumin, bilirubin, alkaline phosphatase, ALT, and AST. It screens kidney function, liver function, electrolyte balance, and fasting glucose in a single draw. The American Diabetes Association (ADA) recommends fasting glucose screening for all adults with BMI of 25 kg/m² or above [3].
Lipid Panel
A standard lipid panel reports total cholesterol, LDL-C, HDL-C, and triglycerides. The 2018 ACC/AHA cholesterol guideline uses these values along with the pooled cohort equation to determine statin eligibility [4]. Triglyceride levels above 150 mg/dL also serve as an independent marker of insulin resistance. Fasting is preferred for accurate triglyceride measurement, though non-fasting LDL-C is considered acceptable by recent European Society of Cardiology guidance.
Complete Blood Count (CBC)
The CBC reports white blood cells, red blood cells, hemoglobin, hematocrit, and platelets. Hematocrit is especially relevant before testosterone therapy. The Endocrine Society's 2018 guideline recommends withholding or adjusting TRT if hematocrit exceeds 54% due to increased thrombotic risk [5]. A low hemoglobin can also explain fatigue symptoms that might otherwise be attributed to thyroid dysfunction.
HbA1c
HbA1c reflects average blood glucose over the preceding 8 to 12 weeks. An HbA1c of 5.7% to 6.4% defines prediabetes; 6.5% or above defines type 2 diabetes [3]. For weight management programs, this value determines whether a GLP-1 agonist is prescribed for obesity alone or for obesity with concurrent glycemic management, which affects both dosing strategy and insurance coverage.
Thyroid Panel (TSH, Free T4, Free T3)
TSH alone is the standard screening test, but it tells an incomplete story. A normal TSH with a low free T3 can indicate poor peripheral conversion of T4 to T3, a pattern common in caloric restriction and chronic stress. The American Thyroid Association (ATA) recommends TSH as the initial screen, with free T4 added when TSH is abnormal [6]. Many metabolic health providers go further and order all three markers upfront to avoid a second blood draw.
Fasting Requirements and Timing
Not all labs require fasting, but grouping them into a single fasting draw simplifies the process. An 8-to-12-hour fast (water is fine) is recommended for the CMP, lipid panel, fasting glucose, and fasting insulin.
What Counts as Fasting
No food, no caloric beverages, no supplements. Black coffee is debated: caffeine can transiently raise cortisol and glucose. The safest approach is water only. Medications you take daily (levothyroxine, blood pressure drugs) should generally still be taken on schedule unless your provider says otherwise. If you take thyroid medication, note the time of your last dose on the lab requisition, since levothyroxine taken within four hours of a blood draw can artificially raise free T4 [7].
Best Time of Day
Morning draws between 7:00 and 9:00 AM give the most reproducible results. Cortisol, testosterone, and TSH all follow circadian rhythms. TSH peaks overnight and drops through the morning, so a draw at 3:00 PM may return a TSH that appears normal when an early-morning value would have flagged subclinical hypothyroidism [8]. Testosterone follows a similar pattern, with peak levels around 8:00 AM that can drop 20 to 30% by afternoon.
How Recent Do Labs Need to Be?
Most providers accept labs drawn within 90 days. For a first visit focused on new symptoms, 30 days is better. If you have been on stable medication for a chronic condition (thyroid replacement, statin therapy), labs within 60 to 90 days are typically sufficient. Check with your specific clinic beforehand. Repeating labs unnecessarily adds cost and another needle stick.
Add-On Panels Based on Your Visit Type
Beyond the five core panels, your provider may request additional markers depending on your clinical picture. These are the most common add-ons organized by visit type.
Weight Management and GLP-1 Visits
Fasting insulin is the single most useful add-on for a weight management visit. While fasting glucose and HbA1c identify hyperglycemia, fasting insulin catches hyperinsulinemia years before glucose rises. A fasting insulin above 10 to 15 µIU/mL with a normal glucose suggests insulin resistance, which responds well to both GLP-1 therapy and metformin [9].
C-reactive protein (hs-CRP) is also increasingly ordered. The CANTOS trial (N=10,061) demonstrated that reducing inflammation independently lowered cardiovascular events [10]. Baseline hs-CRP helps quantify systemic inflammation and track improvement over the course of treatment.
If your provider suspects metabolic-associated steatotic liver disease (MASLD), expect GGT and possibly a FIB-4 index calculation (derived from age, AST, ALT, and platelet count). The American Gastroenterological Association's 2024 clinical practice update recommends FIB-4 as the first-line non-invasive screen for liver fibrosis in patients with metabolic risk factors [11].
Thyroid-Focused Visits
If your visit centers on thyroid symptoms (fatigue, weight changes, cold intolerance, hair thinning), your provider may add thyroid peroxidase antibodies (TPO Ab) and thyroglobulin antibodies (TgAb) to screen for Hashimoto's thyroiditis. Hashimoto's affects roughly 5% of the U.S. Population and is the most common cause of hypothyroidism in iodine-sufficient countries [6].
Reverse T3 (rT3) is a more controversial marker. It rises during caloric restriction, acute illness, and chronic stress, reflecting a shift in T4 metabolism away from the active T3 pathway. Not all endocrinologists find it actionable, but integrative and functional medicine providers often use it to guide T3 supplementation decisions.
Hormone Therapy Consultations (TRT/HRT)
For men considering testosterone replacement, the Endocrine Society recommends measuring total testosterone on two separate mornings, along with LH, FSH, prolactin, hematocrit, and PSA [5]. SHBG (sex hormone-binding globulin) helps calculate free testosterone when total testosterone falls in the borderline range (264 to 400 ng/dL).
For women considering HRT for perimenopause or menopause, labs typically include estradiol, FSH, progesterone, DHEA-S, and a thyroid panel. The North American Menopause Society (NAMS) 2022 position statement notes that while menopause is a clinical diagnosis, lab confirmation helps in ambiguous cases, particularly in women under 45 or those with surgical menopause [12].
Vitamin and Nutrient Panels
Vitamin D (25-hydroxyvitamin D) is the most commonly deficient nutrient in metabolic health patients. A National Health and Nutrition Examination Survey (NHANES) analysis found that 41.6% of U.S. Adults are deficient, defined as levels below 20 ng/mL [13]. Symptoms of deficiency (fatigue, muscle weakness, mood changes) overlap heavily with thyroid and hormone dysfunction, making it an important rule-out.
Vitamin B12 and folate are worth checking if you take metformin, which depletes B12 over time. The ADA acknowledges this interaction and suggests periodic B12 monitoring in long-term metformin users [3].
Iron studies (ferritin, serum iron, TIBC) round out the panel for patients with fatigue. Ferritin below 30 ng/mL, even with a normal hemoglobin, can cause fatigue, hair loss, and exercise intolerance. This is especially common in premenopausal women.
How to Get Your Labs Done Before the Visit
Knowing which labs to get is half the equation. Logistics trip up many patients. Here is the practical side.
Option 1: Your Provider Sends a Requisition
Most clinics, including telehealth programs, will email or fax a lab requisition to a national lab (Quest Diagnostics, Labcorp, or a local draw site). You schedule the appointment yourself, fast appropriately, and results typically arrive in one to three business days.
Option 2: Your Primary Care Doctor Orders Them
If you already have a PCP, ask them to order your metabolic labs at your next annual visit or via a patient portal message. Frame it as preventive screening. Most of these panels (CMP, CBC, lipid panel, HbA1c, TSH) fall under standard preventive care and are covered at no cost under the ACA if you have not had them in the past 12 months.
Option 3: Direct-to-Consumer Lab Services
Services like Walk-In Lab, Ulta Lab Tests, or HealthRX-affiliated lab ordering allow you to purchase panels without a prescription in most states. A comprehensive metabolic and hormone panel runs $100 to $250 out of pocket. This is fastest for people without a PCP or those whose insurance has a high deductible.
What to Bring to the Draw
Bring your photo ID, insurance card (if applicable), and the lab requisition (printed or on your phone). Wear a short-sleeved shirt. Stay hydrated. Dehydration constricts veins and makes the draw harder. Drink 16 to 24 ounces of water in the hour before your appointment.
Reading Your Results Before the Visit
Lab portals now release results directly to patients, often before the physician reviews them. Knowing what to look for reduces anxiety and prepares better questions.
Reference Ranges Are Not Optimal Ranges
A TSH of 4.2 mIU/L is technically within the standard reference range (0.4 to 4.5 mIU/L) at most labs, but the ATA notes that 95% of healthy adults without thyroid disease have a TSH below 2.5 mIU/L [6]. Many metabolic health providers use a tighter functional range of 0.5 to 2.5 mIU/L for TSH. The same principle applies to fasting insulin: a lab reference range might go up to 25 µIU/mL, but values above 10 already suggest early insulin resistance.
Flagged Results Do Not Always Mean Pathology
A slightly elevated ALT after intense exercise, a borderline-low white blood cell count in an athlete, or a transiently high TSH from a 4:00 PM draw can all trigger "H" or "L" flags without clinical significance. Context matters. Write down any recent changes in diet, exercise, medication, or illness to share with your provider.
Patterns Matter More Than Single Values
A fasting glucose of 105 mg/dL alongside an HbA1c of 5.9% and a fasting insulin of 18 µIU/mL tells a coherent story of insulin resistance. That same glucose of 105 with an HbA1c of 5.2% and a fasting insulin of 5 µIU/mL is likely a stress response or a lab artifact. Your provider reads the constellation, not the individual star.
Special Considerations for Telehealth Programs
Telehealth metabolic health programs have proliferated since 2020. Their lab requirements share a common core but differ in specifics.
Calibrate-Style Programs
Programs modeled on the Calibrate approach typically require a CMP, lipid panel, HbA1c, and TSH as a minimum. Some add fasting insulin and a CBC. The results must be uploaded to the patient portal before the first video visit. If results are older than 90 days or missing a required marker, you will be asked to repeat the draw, which can delay your start by one to two weeks.
GLP-1-Specific Requirements
Before prescribing semaglutide or tirzepatide, most responsible programs require documentation of BMI (calculated from height and weight, not a lab value), HbA1c, and a thyroid panel. The FDA's prescribing information for semaglutide notes that it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2]. A baseline calcitonin level is not universally required, but some providers order it for completeness.
State-by-State Lab Order Regulations
Not all states allow telehealth providers to order labs across state lines without an in-state license. In some cases, you may need to use a direct-to-consumer lab service. Check with your program before assuming they can send a requisition to your local lab.
A Pre-Visit Lab Checklist
This summary organizes the labs by priority tier.
Tier 1 (required for nearly every metabolic or hormone visit):
- Comprehensive Metabolic Panel (CMP)
- Complete Blood Count (CBC)
- Lipid Panel (fasting preferred)
- HbA1c
- TSH, Free T4, Free T3
Tier 2 (strongly recommended based on symptoms and goals):
- Fasting insulin
- Vitamin D (25-OH)
- hs-CRP
Tier 3 (add-ons for specific visit types):
- Testosterone (total + free), SHBG, LH, FSH, prolactin (TRT visits)
- Estradiol, progesterone, DHEA-S (HRT visits)
- TPO antibodies, thyroglobulin antibodies (thyroid-focused visits)
- Ferritin, iron, TIBC (fatigue workup)
- GGT, FIB-4 calculation (liver/MASLD screening)
- Vitamin B12 (metformin users)
Schedule your draw for 7:00 to 9:00 AM after an 8-to-12-hour water-only fast, ideally 7 to 14 days before your appointment, so results are back and ready for review during your visit.
Frequently asked questions
›Which labs are needed before my doctor visit?
›Do I need to fast before my lab work?
›How far in advance should I get labs before my appointment?
›Why does my doctor need a thyroid panel for a weight loss visit?
›What is the difference between a basic metabolic panel and a comprehensive metabolic panel?
›Can I order my own labs without a doctor?
›What time of day should I get my blood drawn?
›How long does it take to get lab results back?
›Does insurance cover pre-visit lab work?
›Why is fasting insulin important if my glucose is normal?
›What if my lab results are flagged as abnormal?
›Do telehealth weight loss programs accept labs from my primary care doctor?
References
- Bates DW, et al. Pre-visit laboratory testing and time to clinical decision in primary care. J Gen Intern Med. 2021;36(8):2345-2351. https://pubmed.ncbi.nlm.nih.gov/33948803
- U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s012lbl.pdf
- American Diabetes Association. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625
- Bhasin S, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364
- Jonklaas J, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247
- Benvenga S, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376
- Ehrenkranz J, et al. Circadian and circannual rhythms in thyroid hormones: Determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid. 2015;25(8):954-961. https://pubmed.ncbi.nlm.nih.gov/26061017
- Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. https://diabetesjournals.org/diabetes/article/37/12/1595/7630
- Ridker PM, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS). N Engl J Med. 2017;377(12):1119-1131. https://www.nejm.org/doi/full/10.1056/NEJMoa1707914
- Rinella ME, et al. AGA Clinical Practice Update on MASLD Screening and Risk Stratification. Gastroenterology. 2024;166(6):1098-1111. https://pubmed.ncbi.nlm.nih.gov/38796382
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481
- Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48-54. https://pubmed.ncbi.nlm.nih.gov/21310306